Drug Shortage Report for HEPARIN LEO INJ 1000UNIT/ML
Report ID | 173432 |
Drug Identification Number | 00453811 |
Brand name | HEPARIN LEO INJ 1000UNIT/ML |
Common or Proper name | Sodium Heparin injection |
Company Name | LEO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 1000UNIT |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 10 x 10 mL vial |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-11-03 |
Actual start date | |
Estimated end date | 2022-11-11 |
Actual end date | 2022-11-09 |
Shortage status | Resolved |
Updated date | 2022-11-10 |
Company comments | Increase in demand due to competitor out of stock |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3389 STEELES AVENUE EAST, SUITE 110 TORONTO, ONTARIO CANADA M2H 3S8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-11-10 | English | Compare |
v6 | 2022-11-09 | French | Compare |
v5 | 2022-11-09 | English | Compare |
v4 | 2022-11-04 | English | Compare |
v3 | 2022-11-03 | French | Compare |
v2 | 2022-11-03 | English | Compare |
v1 | 2022-11-03 | English | Compare |
Showing 1 to 7 of 7